Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORAZEPAM Cause Therapeutic product effect incomplete? 476 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 476 reports of Therapeutic product effect incomplete have been filed in association with LORAZEPAM (Lorazepam). This represents 1.4% of all adverse event reports for LORAZEPAM.

476
Reports of Therapeutic product effect incomplete with LORAZEPAM
1.4%
of all LORAZEPAM reports
35
Deaths
252
Hospitalizations

How Dangerous Is Therapeutic product effect incomplete From LORAZEPAM?

Of the 476 reports, 35 (7.4%) resulted in death, 252 (52.9%) required hospitalization, and 52 (10.9%) were considered life-threatening.

Is Therapeutic product effect incomplete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 476 reports have been filed with the FAERS database.

What Other Side Effects Does LORAZEPAM Cause?

Drug ineffective (3,775) Drug abuse (3,741) Toxicity to various agents (2,836) Completed suicide (2,340) Off label use (2,178) Somnolence (2,114) Sopor (2,042) Anxiety (1,573) Fall (1,524) Overdose (1,516)

What Other Drugs Cause Therapeutic product effect incomplete?

ALBUTEROL (8,496) ADALIMUMAB (6,986) PREDNISONE (6,709) METHOTREXATE (6,037) TOFACITINIB (4,914) SECUKINUMAB (4,661) BUDESONIDE\FORMOTEROL (4,392) TIOTROPIUM (4,327) MEPOLIZUMAB (4,106) ETANERCEPT (3,961)

Which LORAZEPAM Alternatives Have Lower Therapeutic product effect incomplete Risk?

LORAZEPAM vs LORCASERIN LORAZEPAM vs LORLATINIB LORAZEPAM vs LORMETAZEPAM LORAZEPAM vs LORNOXICAM LORAZEPAM vs LOSARTAN

Related Pages

LORAZEPAM Full Profile All Therapeutic product effect incomplete Reports All Drugs Causing Therapeutic product effect incomplete LORAZEPAM Demographics